Abstract
Newly emerging pandemics like COVID-19 call for better predictive models to implement early and precisely tuned responses to their deep impact on society. Standard epidemic models provide a theoretically well-founded description of dynamics of disease incidence. For COVID-19 with in-fectiousness peaking before and at symptom onset, the SEIR model explains the hidden build-up of exposed individuals which challenges containment strategies, in particular, due to delayed epidemic responses to non-pharmaceutical interventions. However, spatial heterogeneity questions the adequacy of modeling epidemic outbreaks on the level of a whole country. Here we show that sequential data assimilation of a stochastic version of the standard SEIR epidemic model captures dynamical behavior of outbreaks on the regional level. Such regional modeling of epidemics with relatively low numbers of infected and realistic demographic noise accounts for both spatial heterogeneity and stochasticity. Based on adapted regional models, population level short-term predictions can be achieved. More realistic epidemic models that include spatial heterogeneity are within reach via sequential data assimilation methods.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Our work was supported by a grant from Deutsche Forschungsgemeinschaft, Germany (SFB 1294,project no. 318763901).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are publicly available via Robert Koch Institute (RKI), Berlin, Germany, at https://npgeo-corona-npgeo-de.hub.arcgis.com/, accessed: 2020-04-08; source code (R Language of Statistical Computing) and data used in our study are available via Open Science Framework (OSF).
